Shigeki Shimizu

4.8k total citations · 1 hit paper
108 papers, 3.5k citations indexed

About

Shigeki Shimizu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Shigeki Shimizu has authored 108 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pulmonary and Respiratory Medicine, 45 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Shigeki Shimizu's work include Lung Cancer Treatments and Mutations (37 papers), Lung Cancer Research Studies (13 papers) and Cancer Genomics and Diagnostics (12 papers). Shigeki Shimizu is often cited by papers focused on Lung Cancer Treatments and Mutations (37 papers), Lung Cancer Research Studies (13 papers) and Cancer Genomics and Diagnostics (12 papers). Shigeki Shimizu collaborates with scholars based in Japan, United States and France. Shigeki Shimizu's co-authors include Tetsuya Mitsudomi, Adam B. Olshen, Marc Ladanyi, Valerie W. Rusch, Motoki Yano, Takashi Takahashi, Yoshitaka Fujii, Maureen F. Zakowski, Hidefumi Sasaki and Ryuzo Ueda and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shigeki Shimizu

102 papers receiving 3.5k citations

Hit Papers

The nuclear deubiquitinase BAP1 is commonly inactivated b... 2011 2026 2016 2021 2011 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeki Shimizu Japan 29 1.9k 1.4k 1.0k 481 457 108 3.5k
Teh‐Ying Chou Taiwan 34 1.2k 0.6× 1.1k 0.8× 1.5k 1.4× 641 1.3× 600 1.3× 93 3.6k
Yasuo Saijo Japan 34 2.4k 1.2× 2.7k 1.9× 1.8k 1.7× 671 1.4× 769 1.7× 118 5.2k
Amanda J. Redig United States 22 1.5k 0.8× 1.5k 1.1× 1.2k 1.1× 648 1.3× 222 0.5× 39 3.1k
Fulvio Lonardo United States 32 1.4k 0.7× 1.4k 1.0× 1.3k 1.3× 457 1.0× 197 0.4× 79 3.4k
Ryo Miyahara Japan 35 1.4k 0.7× 1.5k 1.0× 1.1k 1.1× 591 1.2× 275 0.6× 101 3.3k
Yasutomo Nakai Japan 23 973 0.5× 879 0.6× 972 0.9× 617 1.3× 612 1.3× 79 2.8k
Sarah B. Goldberg United States 33 2.7k 1.4× 3.0k 2.1× 1.3k 1.2× 611 1.3× 495 1.1× 143 4.8k
Faye M. Johnson United States 41 1.0k 0.5× 2.1k 1.5× 2.2k 2.1× 629 1.3× 302 0.7× 150 4.4k
Mark N. Kirstein United States 21 1.0k 0.5× 1.4k 1.0× 1.4k 1.4× 365 0.8× 362 0.8× 56 3.4k
Toru Kumagai Japan 32 1.4k 0.7× 1.4k 1.0× 1.1k 1.0× 741 1.5× 288 0.6× 156 3.1k

Countries citing papers authored by Shigeki Shimizu

Since Specialization
Citations

This map shows the geographic impact of Shigeki Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeki Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeki Shimizu more than expected).

Fields of papers citing papers by Shigeki Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeki Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeki Shimizu. The network helps show where Shigeki Shimizu may publish in the future.

Co-authorship network of co-authors of Shigeki Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeki Shimizu. A scholar is included among the top collaborators of Shigeki Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeki Shimizu. Shigeki Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yanagihara, Toyoshi, Ran Nakashima, Hiromitsu Sumikawa, et al.. (2024). Idiopathic Inflammatory Myopathies-Associated Interstitial Lung Disease in Adults. Tuberculosis & respiratory diseases. 88(1). 26–44. 2 indexed citations
3.
Tanaka, Yuya, et al.. (2024). Cutaneous Leukocytoclastic Vasculitis Associated with Pulmonary Tuberculosis and an Anti-tuberculosis Drug. Internal Medicine. 63(18). 2587–2588.
4.
Arai, Toru, Takayuki Takimoto, Naoko Takeuchi, et al.. (2024). Pulmonary fibrosis in pulmonary alveolar proteinosis evaluated by transbronchial lung cryobiopsy: A single-center retrospective study. Respiratory Investigation. 62(6). 1161–1167. 1 indexed citations
5.
Molina, Thierry Jo, Anja C. Roden, Małgorzata Szołkowska, et al.. (2024). International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG study. Lung Cancer. 189. 107479–107479. 1 indexed citations
6.
Uchida, Hiroki, et al.. (2023). The Histological Detection of Ulcerative Colitis Using a No-Code Artificial Intelligence Model. International Journal of Surgical Pathology. 32(5). 890–894. 1 indexed citations
7.
Kobayashi, Yasuyuki, et al.. (2022). Fat‐poor leiomyomatous angiomyolipoma arising from renal parenchyma negative for HMB ‐45: A case report. SHILAP Revista de lepidopterología. 10(12). e6771–e6771. 2 indexed citations
8.
Uchida, Hiroki, et al.. (2022). Aberrant MUC Immunohistochemical Expressions in Inflammatory Bowel Diseases. Applied immunohistochemistry & molecular morphology. 31(2). 107–112. 5 indexed citations
9.
Haratani, Koji, Hidetoshi Hayashi, Shigeki Shimizu, et al.. (2020). Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation–Positive Non–Small Cell Lung Cancer. Clinical Cancer Research. 26(8). 2037–2046. 172 indexed citations
10.
Ohara, Shuta, Kenji Tomizawa, Shigeki Shimizu, et al.. (2019). Primary pulmonary mucosa-associated lymphoid tissue lymphoma with amyloid light chain-type amyloidosis. SHILAP Revista de lepidopterología. 5(1). 105–105.
11.
Suda, Kenichi, Masaki Shimoji, Shigeki Shimizu, et al.. (2019). Comparison of PD-L1 Expression Status between Pure-Solid Versus Part-Solid Lung Adenocarcinomas. Biomolecules. 9(9). 456–456. 9 indexed citations
12.
Tomizawa, Kenji, Shigeki Shimizu, Shuta Ohara, et al.. (2017). Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancer. Lung Cancer. 112. 57–61. 11 indexed citations
13.
Kawaguchi, Tomoya, Masahiko Ando, Norimasa Ito, et al.. (2013). Rationale and Design of the Japan Molecular Epidemiology for Lung Cancer Study. Clinical Lung Cancer. 14(5). 596–600. 3 indexed citations
14.
Brevet, Marie, Shigeki Shimizu, Matthew J. Bott, et al.. (2011). Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy. Journal of Thoracic Oncology. 6(5). 864–874. 51 indexed citations
15.
Naniwa, Taio, et al.. (2010). Hepatitis B Virus-Related Polyarteritis Nodosa Presenting With Multiple Lung Nodules and Cavitary Lesions. CHEST Journal. 138(1). 195–197. 10 indexed citations
16.
Yoshizawa, Akihiko, Junya Fukuoka, Shigeki Shimizu, et al.. (2009). Overexpression of Phospho-eIF4E Is Associated with Survival through AKT Pathway in Non–Small Cell Lung Cancer. Clinical Cancer Research. 16(1). 240–248. 127 indexed citations
17.
18.
Haneda, Hiroshi, Hidefumi Sasaki, Neal I. Lindeman, et al.. (2006). A Correlation between EGFR Gene Mutation Status and Bronchioloalveolar Carcinoma Features in Japanese Patients with Adenocarcinoma. Japanese Journal of Clinical Oncology. 36(2). 69–75. 55 indexed citations
19.
Gaur, Praveen Kumar, Shigeki Shimizu, & Kurtis R. Bray. (1987). Measurement of serum levels of ca 549 an experimental breast cancer marker by photon elite random access analyzer. Clinical Chemistry. 33(6). 930. 1 indexed citations
20.
Satoh, Kunihiko, et al.. (1982). . JOURNAL OF THE JAPAN WELDING SOCIETY. 51(2). 98–105. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026